Carcinoma of Pancreatobiliary Origin
Status PubMed-not-MEDLINE Jazyk angličtina Země Spojené státy americké Médium electronic-ecollection
Typ dokumentu úvodníky
PubMed
32831824
PubMed Central
PMC7426785
DOI
10.1155/2020/4323687
Knihovny.cz E-zdroje
Zobrazit více v PubMed
The European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut. 2018;67(5):789–804. doi: 10.1136/gutjnl-2018-316027. PubMed DOI PMC
Tanaka M., Fernández-Del Castillo C., Kamisawa T., et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology. 2017;17(5):738–753. doi: 10.1016/j.pan.2017.07.007. PubMed DOI
Klöppel G., Adsay V., Konukiewitz B., Kleeff J., Schlitter A. M., Esposito I. Precancerous lesions of the biliary tree. Best Practice & Research. Clinical Gastroenterology. 2013;27(2):285–297. doi: 10.1016/j.bpg.2013.04.002. PubMed DOI
Katabi N., Torres J., Klimstra D. S. Intraductal tubular neoplasms of the bile ducts. The American Journal of Surgical Pathology. 2012;36(11):1647–1655. doi: 10.1097/PAS.0b013e3182684d4f. PubMed DOI
Jusakul A., Khuntikeo N., Haigh W. G., et al. Identification of biliary bile acids in patients with benign biliary diseases, hepatocellular carcinoma and cholangiocarcinoma. Asian Pacific Journal of Cancer Prevention. 2012;13(Supplement):77–82. PubMed
Nishikawa T., Tsuyuguchi T., Sakai Y., Sugiyama H., Miyazaki M., Yokosuka O. Comparison of the diagnostic accuracy of peroral video-cholangioscopic visual findings and cholangioscopy-guided forceps biopsy findings for indeterminate biliary lesions: a prospective study. Gastrointestinal Endoscopy. 2013;77(2):219–226. doi: 10.1016/j.gie.2012.10.011. PubMed DOI
Zar S., Kohoutová D., Bureš J. Pancreatic adenocarcinoma: epidemiology, role of EUS in diagnosis, role of ERCP, endoscopic palliation. Acta Medica (Hradec Králové) 2019;62(4):131–136. doi: 10.14712/18059694.2020.1. PubMed DOI
Janssen Q. P., O'Reilly E. M., van Eijck C. H. J., Groot Koerkamp B. Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer. Frontiers in Oncology. 2020;10:1–13. doi: 10.3389/fonc.2020.00041. PubMed DOI PMC
Nakazawa J., Otsuka T., Shimokawa M., et al. A multicenter retrospective study of gemcitabine plus nab-paclitaxel or FOLFIRINOX in metastatic pancreatic cancer: NAPOLEON study. Annals of Oncology. 2019;30:iv17–iv18. doi: 10.1093/annonc/mdz155.064. DOI
Dumonceau J. M., Tringali A., Papanikolaou I. S., et al. Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline - updated October 2017. Endoscopy. 2018;50(9):910–930. doi: 10.1055/a-0659-9864. PubMed DOI